Abstract The therapeutic potential of human embryonic stem cells (hESCs) has long been appreciated, and the recent FDA approval of hESC derivatives for cell-based therapy encourages the clinical application of hESCs. Here, using CHA3-hESCs with normal and abnormal karyotypes, we report the importance of maintaining normal chromosomes during in vitro culture and the differentiation of hESCs for minimization of posttransplantation complications. We found that undifferentiated CHA3-hESCs with trisomy chromosome 12 undergo abnormal cell division with multiple spindles in comparison to the bipolar cell division of the karyotypically normal CHA3-hESCs. Transplanted karyotypically abnormal CHA3-hESC derivatives formed a tumor-like tissue 6 weeks after transplantation in two out of seven mice tested. Our results demonstrate that the preservation of normal chromosomes is indispensable for maintaining the true properties of hESCs in vitro and abolishing adverse effects posttransplantation. Thus, the development of optimized techniques for stabilizing the chromosome state during in vitro hESC culture is a prerequisite for the therapeutic application of hESCs.
Introduction
Human embryonic stem cells (hESCs) have been widely regarded as a new cell source for regenerative therapy of currently untreatable human diseases (Thomson et al., 1998) . However, their prolonged culture in vitro is subject to chromosomal instability (Buzzard et al., 2004; Yang et al., 2008a) , especially numerous changes in chromosomes 12 and 17, which presents a challenge to the safe therapeutic application of hESCs as they have potential for tumor progression (Clark et al., 2004; Draper et al., 2004) . Chromosomal instability is a phenomenon that indicates an increased rate of numerous changes of whole chromosomes. It is a hallmark of many tumors (Lengauer et al., 1997; D'Assoro et al., 2002; Nigg, 2002; Sluder and Nordberg, 2004) and is generated by the presence of extra centrosomes that promote multipolar anaphase, giving rise to multiple aneuploid daughter cells with proliferative advantages, metastatic potential, or chemoresistance (Gao et al., 2007; Nowell, 1976; Ganem et al., 2009; Rajagopalan and Lengauer, 2004; Weaver et al., 2007) .
In this study, we emphasize the importance of sustaining normal human chromosomes during in vitro culture and differentiation for safe transplantation of derivatives. By observing the aberrant cell division of karyotypically abnormal hESCs using confocal microscopy, we provide supporting evidence that chromosomes are unstable during in vitro culture. In addition, to compare in vivo survival and chromosome stability of hESC-derived cell types after transplantation, a chimney was positioned on the peripheral site of a surgically wounded mouse model transplanted with endothelial cells derived from red fluorescence protein (RFP)-transfected normal and abnormal hESCs (Levenberg et al., 2002; Cho et al., 2007; Kim et al., 2007a) . A 6-week, long-term follow-up study showed that the derivatives of normal RFP-hESCs survived and carried normal human chromosomes. However, when derivatives from abnormal hESCs were transplanted, they formed a tumor-like tissue after 6 weeks of implantation in two out of the seven mice tested. Our results show that hESC chromosomes are unstable during in vitro culture and normal chromosome status is indispensable for safe transplantation of their derivatives for therapeutic use.
Results

Genetic alteration of hESCs and their characteristics
In this study, we used our established CHA3-hESCs (Fig. 1A ) (Cho et al., 2007) , which have a normal chromosome number, i.e., 44 + XY (Fig. 1B) . To characterize the hESCs in vitro, we examined the expression of a pluripotency marker, Oct-4, by immunocytochemistry (Figs. 1A and C). Next, to investigate the pluripotent potential of the hESCs in vivo, we injected the undifferentiated CHA3-hESCs (3 × 10 5 cells) into the dorsal region of NOD/SCID mice and euthanized the mice 12 weeks later. Histological analysis showed tissues representing all three germ layers in the teratomas extracted from the mice by immunohistochemistry . From these results, we concluded that the CHA3-hESC line possessed general hESC characteristics in vitro and in vivo.
During normal CHA3-hESC culture (Fig. 1A) , we discovered that trisomy of chromosome 12 had occurred in CHA3-hESCs (Fig. 1H) , among the cultured cells under normal hESC culture conditions. It has been reported that cultured hESCs are prone to karyotypic instability during extensive in vitro proliferation and, consequently, undergo cell division reminiscent of cancer cells (Draper et al., 2004; Baker et al., 2007) . To examine this possibility, we performed immunocytochemistry on karyotypically normal (Fig. 1B) and abnormal (Fig. 1H , trisomy of chromosome 12) CHA3-hESCs using antibodies against an undifferentiated (Oct-4) and spindle marker (α-tubulin) phenotype. As a result, we observed that euploid hESCs underwent symmetrical cell division with bipolar spindles (Fig. 1C) , but aneuploid cells, which acquired an extra chromosome 12 during in vitro proliferation, abnormally divided with multiple spindles (Fig. 1I) . To further investigate the pluripotent potential of the abnormal hESCs in vivo, we injected the undifferentiated CHA3-hESCs with trisomy of chromosome 12 (3 × 10 5 cells) into the dorsal region of NOD/SCID mice and euthanized the mice 12 weeks later. Endothelial cell differentiation capacity of normal and abnormal CHA3-hESCs
To compare the differentiation potentials of normal and abnormal CHA3-hESCs, we induced endothelial cell differentiation from normal and abnormal hESCs using hEB formation as previously described (Cho et al., 2007; Kim et al., 2007b) (Fig. 2A) . Immunocytochemical analysis showed that the expression pattern of PECAM, an endothelial cell-specific marker, first appeared at the central region of differentiated hEBs ( Fig. 2A , hEB formation stage) and was continuously expressed at the central region of attached hEBs (Figs. 2B-D). The well-known neuronal marker, TuJ1 were used to label ectodermal lineage cells that first appeared near the surface of hEBs (data not shown) and were continuously expressed at the surface and outgrowth regions of attached hEBs (Figs. 2C and D) . The magnified image presented in the red box of Fig. 2C shows that these PECAM and TuJ1-expressing cells were distinguishable (Fig. 2E) , and different positions of these two markers were observed in the z-axis image shown in Fig. 2E ( Fig. 2F) . Next, to enrich for populations of endothelial cells in the attached condition, we supplemented the DMEM medium containing 10% FBS with VEGF (Bernatchez et al., 1999; Wang et al., 2007; Yang et al., 2008b) for induction of endothelial cells after plating the hEBs. After 3 days of VEGF treatment, the number of PECAM-expressing cells dramatically increased compared to the culture without VEGF (Figs. 2B-F), and many tubule-like structures formed by PECAM-positive cells were observed under the VEGF-treated conditions (Fig. 2G ) compared to without VEGF (Fig. 2E) . Additionally, PECAM expression was no longer restricted to the clusters but migrated toward the peripheral outgrowth region where TuJ1-positive neuronal cells were localized (Fig. 2H ). These data show that VEGF treatment enriches for PECAM-positive cells and induces cell differentiation by changing the normal differentiation pattern. Taken together, although CHA3-hESCs with trisomy of chromosome 12 could have an abnormal proliferative property through aberrant cell division, their ability to differentiate into endothelial cells was unaffected when compared to karyotypically normal CHA3-hESCs.
Generation of RFP-hESCs and their ability to differentiate into endothelial cells
To examine the chromosome stability and proliferation potential of normal or abnormal CHA3-hESCs derivatives post transplantation in vivo, we transfected hESCs with mRFP using lentivirus to visualize the fate of implanted cells using Xenogeny equipment ( Fig. 3A ) (van der Bogt et al., 2006; Cao et al., 2008; Ilagan et al., 2006) . First, hESCs harboring RFP (Fig. 3B ) were generated using our previously described technique (Kim et al., 2007a) and spontaneously differentiated via EB formation (Fig. 3C ). Endothelial cells derived from hESCs ( Fig. 3D) were FACS-sorted as previously described ( Fig. 2A and Supplementary  Fig. 1 ) (Levenberg et al., 2002; Cho et al., 2007) , and we confirmed the persistent expression of RFP in the differentiated cells (Fig. 3D) . Next, to investigate the chromosome stability during endothelial cell differentiation of undifferentiated RFPexpressing hESCs, we analyzed the karyotype of hESC-ECs derived from undifferentiated normal or abnormal hESCs, respectively. Chromosomal alterations were not detected between undifferentiated hESCs and their derivatives in our differentiation system in vitro (Figs. 3E and F) .
The fate of hESC derivatives carrying normal or abnormal chromosomes after in vivo transplantation
After confirmation of chromosome stability during the differentiation of RFP-expressing hESC-ECs derived from normal or abnormal hESCs in vitro, we first analyzed the chromosome stability and survival potential of RFP-expressing hESC-ECs carrying a normal chromosome in a newly developed mouse wound model with a custom-designed polypropylene circular ring (Figs. 4A-C) by Xenogeny. At 6 weeks postimplantation, the cells still expressed the RFP signal robustly as compared to the PBS group (Figs. 4D and E). To precisely confirm whether the RFP signals were expressed by the surviving cells, we isolated the cells within the circular ring and cultured them on tissue culture plates in vitro. We found that the isolated cells expressed RFP (Fig. 4E, white arrowhead) . Next, to assess whether RFPpositive cells were of human origin and carried normal human chromosomes, we performed karyotypic analysis on the isolated RFP-positive cells by FACS sorting and confirmed that they had normal human chromosomes (Fig. 4E) .
However, when RFP-hESC-ECs carrying a trisomy of chromosome 12 were implanted in this model, a tumor-like tissue was formed after 6 weeks of implantation in two out of the seven mice tested (Fig. 5A ). When the tissue was prepared for immunohistochemistry with hematoxylin and eosin (H&E) and special staining methods, the results did not show the presence of all three germ layers, in contrast to the results shown in Fig. 1  (Figs. 5B-E) , but the proliferation of many cells in a tumor-like tissue was observed by H&E staining (Fig. 5B) . In addition, when the cells from the tissue were cultured in vitro, they demonstrated a faster proliferation rate (Supplementary Fig. 2A ) and morphologically homogeneous cell types (Fig. 5F ). However, they showed the low invasion potential comparison with endothelial progenitor cells and normal hESC-ECs (Supplementary Fig. 2B ) (Cross et al., 1994) ; in addition, the majority of the cells expressed RFP (Fig. 5G) . RFP-expressing cells were sorted by FACS and subjected to karyotypic analysis, which revealed abnormalities in various chromosomes (Figs. 5H and I ). These data indicate that the ability to sustain normal chromosomes during the maintenance and differentiation of hESCs is important for cell therapy using hESC derivatives.
Discussion
Controlling the chromosome stability of hESCs and their derivatives remains a fundamental challenge in trials of hESC derivative-based cell therapy. In 2004, Andrew and co-workers reported that chromosomal instability during extensive hESC expansion was due to the adaptation status of hESCs during in vitro culture (Draper et al., 2004) . In particular, chromosomal aberrations have been frequently reported for chromosomes 12 and 17, and this phenomenon was thought to lead to tumor progression (Yang et al., 2008a) . In this present study, we compared and examined abnormal cell division with multipolar spindles during aneuploid hESC cell division in in vitro culture. We confirmed that hESCs carrying a trisomy of chromosome 12 underwent aberrant cell division with multiple spindles (Fig. 1I ) and provided clear evidence that cells with an aberrant chromosome 12 propagated similarly to cancer-like cells (Sluder et al., 1997; Chen and Horwitz, 2002; Brinkley and Goepfert, 1998) . The common occurrence of changes in chromosome 12 during in vitro culture conditions indicates that if the condition is not monitored closely, hESCs can easily become cancer-like or embryonic carcinoma cells (Draper et al., 2004; Gertow et al., 2007) . Thus, it is critical to examine the cause of the chromosome instability and develop optimized culture techniques. Figure 2A (hEB formation) shows that PECAM-expressing cells within hEBs derived from abnormal hESCs were similar to our previous work which has demonstrated that PECAM-positive cells are localized in the center of normal hEBs (Cho et al., 2007; Kim et al., 2007b) . Chromosome instability with trisomy of chromosome 12 affects the proliferative potential of undifferentiated hESCs in culture but does not influence them during endothelial cell differentiation in the present study. Finally, we assessed the survival of karyotypically normal and abnormal hESC derivatives in vivo and their potential to undergo chromosomal changes after transplantation. Numerous researchers have transplanted hESC derivatives in animal models and confirmed their survival and functionality in vivo (Cho et al., 2007; Laflamme et al., 2007; Lu et al., 2007) , but the potential chromosomal changes of the donor cells in vivo have not been studied. In addition, many researchers have attempted to analyze in vivo cell survival using cell tracking (Brazelton and Blau, 2005) , molecular imaging (van der Bogt et al., 2006) , and gene transfection (Li et al., 2008) but have failed to provide accurate results (Swenson et al., 2007; Pawelczyk et al., 2008) . To overcome the above-noted problems, we established RFP-hESCs (Fig. 3 ) using a lentivirus system and produced a new animal model with a wound using a PE chimney for observation of transplanted cells (Fig. 4) . Using our developed system together with techniques such as RFP transfection, euploid and aneuploid hESCs carrying a trisomy of chromosome 12 were induced to differentiate and analyzed for 6 weeks after transplantation into an animal model. Transplanted euploid hESC derivatives maintained normal human chromosome numbers, but aneuploid hESC derivatives continued to undergo further chromosomal changes in two among the seven mice tested. These results demonstrate the importance of maintaining normal human chromosomes prior to transplantation; the safety of hESC derivatives carrying normal human chromosomes is improved compared with those carrying abnormal chromosomes.
In summary, we first discovered that the chromosome instability with trisomy of chromosome 12 in hESCs caused them to divide with multiple spindles and increased the proliferative potential of undifferentiated hESCs but did not affect the differentiation of endothelial cells. Second, we found that the chromosome instability of hESC derivatives gave rise to a tumor-like tissue in vivo in the absence of teratomas, using RFP-hESCs and a newly developed wound model to analyze the fate of injected hESCs derivatives. Thus, our approach used to assess the importance of chromosome stability in hESCs revealed that the chromosome instability of hESCs with trisomy of chromosome 12 during maintenance changed the proliferative potential of hESCs via cell division with multiple spindles in vitro and their derivatives, which formed a tumor-like tissue in vivo. Based on these results, we suggest that optimized culture techniques that sustain the chromosome stability of hESCs should be required for clinical trials using hESC derivatives.
Materials and methods
hESC culture, hEB formation, and differentiation into endothelial cells Gibco BRL, Gaithersburg, MD) supplemented with 20% (v/v) serum replacement (Gibco) and basic ES medium components including 1 mM L-glutamine (Gibco), 1% nonessential amino acids (Gibco), 100 mM beta-mercaptoethanol (Gibco), and 4 ng/mL bFGF (Invitrogen, Grand Island, NY). The medium was changed every 24 h, and the hESCs were transferred to new feeder cells every 5-7 days with dissecting pipettes. For EB formation, hESCs were detached from the feeder cells with dispase (Gibco), transferred to Petri dishes, and then suspended in bFGF-free hESC culture medium for 7 days (Cho et al., 2007; Kim et al., 2007b) . To differentiate hESCs into endothelial cells, hEBs were split onto a 0.1% gelatin-coated plate and cultured in DMEM medium supplemented with 10% FBS (Gibco) for 5 days. Subsequently, to enrich for attached cells, the medium was replaced with DMEM supplemented with 10% FBS and 20 ng/ ml VEGF medium for 5 days. To isolate endothelial cells from hESC derivatives, cell sorting using FITC-conjugated mouse anti-human monoclonal PECAM antibody (BD Biosciences, Bedford, MA) was performed with a FACS Vantage flow cytometer (BD Biosciences) (Levenberg et al., 2002) ( Fig. 2A) . The sorted cells were cultured in EGM-2MV (Clonetics, San Diego, CA).
mRFP lentiviral vector construct and virus production
The lentiviral vector construct (CSII-EF-mRFP1) used in our study was donated by Dr. Hiroyuki Miyoshi. The construct contains common domains such as a central polypurine tract, central termination sequence, promoter region, and woodchuck hepatitis virus (Fig. 3A) . The human immunodeficiency virus type 1 expressing the mRFP gene was produced by transient transfection into 293 T cells. Briefly, about 70% confluent 293 T cells in a 15-cm dish were transfected using the calcium phosphate transfection buffer with plasmid DNA: the envelope plasmid pRSV-REV harboring the gene encoding VSV-G, the packaging plasmid pCAG-HIVgp, and the transfer vector. The medium was replaced after 12 to 16 h with DMEM (Gibco) supplemented with 10% FBS. The medium containing the viral particles was collected 48 h after transfection and filtered through 0.45-nm filters. Virus was concentrated at 50 000 g at 4°C for 4 h. Viral titers (TU/ml) were determined by transfection of 293 T cells with serial dilutions of the viral supernatant and FACS analysis of the percentage of mRFPexpressing cells. Titers of the concentrated lentiviral vector ranged from 1 to 2 × 10 8 transducing units per milliliter.
Transfection of hESCs with mRFP virus particles
Before transfection, hESCs were trypsinized and plated onto BD Matrigel hESC-qualified matrix-coated culture dishes. The hESCs were transfected after 24 h of plating with medium containing viral particles by incubating for 10 h. After 10 h, the hESCs were washed with culture medium and continuously cultured. Next, RFP-expressing cells were sorted using a FACSVantage flow cytometer. The sorted cells were cultured in bFGF-containing hESC culture medium (Kim et al., 2007a; Braam et al., 2008) (Fig. 3B) .
Karyotype analysis
Chromosome analysis was performed according to standard methods with minor modifications (Dutrillaux and ViegasPequignot, 1981) . Three days after replating, hESCs were incubated with 100 μl of colcemid (Gibco) for 3 h at 37°C in a CO 2 incubator and then detached by 0.25% trypsin-EDTA. After treatment with a hypotonic solution (1% citrate buffer), lysed cells were fixed in fixation solution (ethanol: glacial acetic acid at 3:1). G-banding was observed for identification of chromosomes. Karyotype analysis was performed at a genetic analysis laboratory in CHA General Hospital (Kim et al., 2007a) .
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100 in PBS (Gibco) for 5 min. After treatment with 1% normal goat serum for 30 min, the cells were incubated with Oct-4 (Santa Cruz Biotechnology Inc., Santa Cruz, CA), Tra-1-60, TuJ1, α-tubulin (Abcam Inc., Cambridge, MA), and PECAM (Millipore) antibodies for 12 h at 4°C. Cells were washed with PBS and then incubated with rhodamine-conjugated or FITC-conjugated secondary antibodies (Molecular Probes Inc., Eugene, OR) for 1 h. The stained slides were mounted with a glycerol-based mounting solution containing 2.5% polyvinyl alcohol and 1,4-diazabicyclooctane with DAPI (Sigma). All images were analyzed with a LSM 510 META confocal microscope (Carl Zeiss Inc., Oberkochen, Germany).
Animal model and in vivo fluorescence imaging
All animals were cared for humanely in compliance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (National Institutes of Health publication No. 85-23, revised 1996) . Male athymic nude mice (Jungang Laboratory Animal, Seoul, Korea), aged 6 weeks and weighing 25 to 30 g, were anesthetized by intraperitoneal injection of 100 μl of a solution containing xylazine (20 mg/kg) and ketamine (100 mg/kg). After the dorsal surface of each mouse had been disinfected with an alcohol swab, a full-thickness excisional wound (1.2 cm in diameter) was created on the dorsal-medial back of each animal, using a standard skin biopsy punch (Acuderm Inc., Fort Lauderdale, FL). Immediately after surgery, wounds were fixed by insertion of a custom-designed polypropylene circular ring (inner diameter 11 mm). The wound in the ring was covered with 3 × 10 5 PECAM-expressing cells from normal or abnormal CHA3-hESC derivatives or a PBS mixture, with growth factor reduced BD Matrigel to reduce cell migration within the transplanted region. Finally, the wound was covered with transparent film (Opsite, Smith & Nephew) placed on the top of the polypropylene ring to prevent leaking and drying. Three experimental groups of male athymic nude mice were established in this study: a shamoperated group with untreated wounds (control), wounds treated with normal chromosome hESC-derived PECAMexpressing cells, or abnormal chromosome hESC-derived PECAM-expressing cells. Each group underwent experiments to evaluate all wounds for 6 weeks postsurgery (n = 7 for each group). In vivo fluorescence images of RFP-expressing, PECAM-expressing cell-transplanted mice were observed using a Xenogen IVIS imaging system (Xenogen Corp., Alameda, CA).
Teratoma formation and immunohistochemical analyses
Undifferentiated hESCs (3 × 10 5 ) were injected into the dorsal region of 6-week-old, nonobese, diabetic/severe combined immunodeficiency (NOD/SCID) mice (The Jackson Laboratory, Bar Harbor, ME). The resulting teratomas were removed 12 weeks later. Samples from the teratomas were paraffin-embedded and serially sectioned (5 μm) using a microtome (Leica Microsystems, Wetzlar, Germany) . To analyze the three germ-layer lineage cells derived from injected hESCs in the teratomas, sectioned slides were histologically examined by hematoxylin and eosin for the gut epithelium and special stains as follows: PAS stain for the secretory epithelium, Alcian blue stain for cartilage, and Masson's trichrome stain for muscle fibers. Images were analyzed using an inverted microscope system (Nikon).
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